In our study, patients with neovascular glaucoma that was refractory to treatment showed higher levels of IL-6, TGFβ-1, and VEGF than other PDR patients, which implies that the levels of these three factors are correlated with the severity of PDR. This evidence concerns the gene VEGFA and neovascular glaucoma.